List all clinical trials by discovery date. Accepts regular expressions in search.

GET /trials/?page=69
HTTP 200 OK
Allow: GET, POST, HEAD, OPTIONS
Content-Type: application/json
Vary: Accept

{
    "count": 768,
    "next": "http://api.gregory-ms.com/trials/?page=70",
    "previous": "http://api.gregory-ms.com/trials/?page=68",
    "results": [
        {
            "trial_id": 88,
            "title": "Evaluation of Safety, Tolerability and Preliminary Efficacy of EHP-101 in Relapsing Forms of Multiple Sclerosis",
            "summary": "<b>Condition</b>:    Relapsing Forms of Multiple Sclerosis<br/><b>Interventions</b>:    Drug: EHP-101 25 mg OD;   Drug: EHP-101 25 mg BID;   Drug: EHP-101 50 mg OD;   Drug: EHP-101 50 mg BID<br/><b>Sponsor</b>:    Emerald Health Pharmaceuticals<br/><b>Not yet recruiting</b>",
            "published_date": "2021-05-31T16:00:00Z",
            "discovery_date": "2021-06-01T17:47:28Z",
            "link": "https://clinicaltrials.gov/ct2/show/NCT04909502?cond=Multiple+Sclerosis&sfpd_d=14&sel_rss=new14",
            "source": "Clinical Trials.gov",
            "relevant": null
        },
        {
            "trial_id": 89,
            "title": "A Comprehensive Assessment of Trunk, Scapula and Upper Limb in Neurological Patients. Reliability, Validity and Interrelatedness",
            "summary": "<b>Conditions</b>:    Multiple Sclerosis;   Stroke<br/><b>Interventions</b>:    Other: Clinical Scapular protocol (ClinScaP);   Other: the prevalence of trunk, scapula and upper limb impairments.;   Other: the interaction between trunk, scapula and upper limb impairments.<br/><b>Sponsors</b>:    Hasselt University;   Revalidatie & MS Centrum Overpelt;   Ziekenhuis Oost-Limburg;   National MS Center Melsbroek;   Jessa Hospital<br/><b>Recruiting</b>",
            "published_date": "2021-05-31T16:00:00Z",
            "discovery_date": "2021-06-01T17:47:28Z",
            "link": "https://clinicaltrials.gov/ct2/show/NCT04908891?cond=Multiple+Sclerosis&sfpd_d=14&sel_rss=new14",
            "source": "Clinical Trials.gov",
            "relevant": null
        },
        {
            "trial_id": 87,
            "title": "Creating Satisfying Engagement in Daily Life Through Coaching for People With Multiple Sclerosis",
            "summary": "<b>Conditions</b>:    Multiple Sclerosis;   Quality of Life<br/><b>Intervention</b>:    Behavioral: Occupational Performance Coaching<br/><b>Sponsor</b>:    Queen's University<br/><b>Not yet recruiting</b>",
            "published_date": "2021-05-31T16:00:00Z",
            "discovery_date": "2021-06-01T17:47:28Z",
            "link": "https://clinicaltrials.gov/ct2/show/NCT04908085?cond=Multiple+Sclerosis&sfpd_d=14&sel_rss=new14",
            "source": "Clinical Trials.gov",
            "relevant": null
        },
        {
            "trial_id": 84,
            "title": "The Therapeutic Effects of Forced Aerobic Exercise in Multiple Sclerosis",
            "summary": "<b>Condition</b>:    Multiple Sclerosis<br/><b>Interventions</b>:    Behavioral: Forced Aerobic Exercise (FE);   Behavioral: Voluntary Aerobic Exercise (VE)<br/><b>Sponsor</b>:    The Cleveland Clinic<br/><b>Not yet recruiting</b>",
            "published_date": "2021-05-28T16:00:00Z",
            "discovery_date": "2021-05-28T12:44:08Z",
            "link": "https://clinicaltrials.gov/ct2/show/NCT04906057?cond=Multiple+Sclerosis&sfpd_d=14&sel_rss=new14",
            "source": "Clinical Trials.gov",
            "relevant": null
        },
        {
            "trial_id": 86,
            "title": "Evaluation of New MRI Sequences Including 3D-FGAPSIR for the Optimization of Inflammatory Spinal Cord Lesions Research",
            "summary": "<b>Condition</b>:    Estimate the Number of Spinal Cord Lesions Detected With the 3D FGAPSIR Sequence That Were Not Detected With the 3D PSIR Sequence<br/><b>Intervention</b>:    Device: MRI<br/><b>Sponsor</b>:    Fondation Ophtalmologique Adolphe de Rothschild<br/><b>Enrolling by invitation</b>",
            "published_date": "2021-05-28T16:00:00Z",
            "discovery_date": "2021-05-28T12:44:08Z",
            "link": "https://clinicaltrials.gov/ct2/show/NCT04906928?cond=Multiple+Sclerosis&sfpd_d=14&sel_rss=new14",
            "source": "Clinical Trials.gov",
            "relevant": null
        },
        {
            "trial_id": 85,
            "title": "Next-Gen MS: Feed-forward PRO Data for MS Research",
            "summary": "<b>Condition</b>:    Multiple Sclerosis<br/><b>Intervention</b>:    <br/><b>Sponsor</b>:    EMD Serono Research & Development Institute, Inc.<br/><b>Not yet recruiting</b>",
            "published_date": "2021-05-28T16:00:00Z",
            "discovery_date": "2021-05-28T12:44:08Z",
            "link": "https://clinicaltrials.gov/ct2/show/NCT04907305?cond=Multiple+Sclerosis&sfpd_d=14&sel_rss=new14",
            "source": "Clinical Trials.gov",
            "relevant": null
        },
        {
            "trial_id": 83,
            "title": "Pilot Investigation to Evaluate FlowOx2.0™ for Experimental Treatment of Spasticity",
            "summary": "<b>Conditions</b>:    Multiple Sclerosis;   Spasticity, Muscle;   Pain<br/><b>Intervention</b>:    Device: FlowOx™<br/><b>Sponsors</b>:    Otivio AS;   Haukeland University Hospital<br/><b>Recruiting</b>",
            "published_date": "2021-05-27T16:00:00Z",
            "discovery_date": "2021-05-27T12:09:08Z",
            "link": "https://clinicaltrials.gov/ct2/show/NCT04904016?cond=Multiple+Sclerosis&sfpd_d=14&sel_rss=new14",
            "source": "Clinical Trials.gov",
            "relevant": null
        },
        {
            "trial_id": 82,
            "title": "The Possible Neuroprotective Effect of Ocrelizumab Via VEGF Protein Expression in Relapsing Multiple Sclerosis Patients",
            "summary": "<b>Condition</b>:    Multiple Sclerosis Relapse<br/><b>Intervention</b>:    <br/><b>Sponsor</b>:    IRCCS National Neurological Institute "C. Mondino" Foundation<br/><b>Not yet recruiting</b>",
            "published_date": "2021-05-26T16:00:00Z",
            "discovery_date": "2021-05-26T15:30:08Z",
            "link": "https://clinicaltrials.gov/ct2/show/NCT04902690?cond=Multiple+Sclerosis&sfpd_d=14&sel_rss=new14",
            "source": "Clinical Trials.gov",
            "relevant": null
        },
        {
            "trial_id": 81,
            "title": "Swiss Study of the Impact of Mayzent on SPMS Patients in a Long-term Non-interventional Study",
            "summary": "<b>Condition</b>:    Secondary Progressive Multiple Sclerosis With Inflammatory Disease Activity<br/><b>Intervention</b>:    Other: Siponimod<br/><b>Sponsor</b>:    Novartis Pharmaceuticals<br/><b>Not yet recruiting</b>",
            "published_date": "2021-05-20T16:00:00Z",
            "discovery_date": "2021-05-20T11:40:26Z",
            "link": "https://clinicaltrials.gov/ct2/show/NCT04895202?cond=Multiple+Sclerosis&sfpd_d=14&sel_rss=new14",
            "source": "Clinical Trials.gov",
            "relevant": null
        },
        {
            "trial_id": 80,
            "title": "Adapting mHealth Technology to Improve Patient Activation",
            "summary": "<b>Conditions</b>:    Spinal Cord Injuries;   Stroke;   Multiple Sclerosis<br/><b>Intervention</b>:    Behavioral: Fatigue self-management SMS intervention<br/><b>Sponsors</b>:    Washington University School of Medicine;   The Foundation for Barnes-Jewish Hospital<br/><b>Recruiting</b>",
            "published_date": "2021-05-19T16:00:00Z",
            "discovery_date": "2021-05-19T11:05:28Z",
            "link": "https://clinicaltrials.gov/ct2/show/NCT04893590?cond=Multiple+Sclerosis&sfpd_d=14&sel_rss=new14",
            "source": "Clinical Trials.gov",
            "relevant": null
        }
    ]
}